LAPADULA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 319
EU - Europa 153
AS - Asia 36
SA - Sud America 8
AF - Africa 7
OC - Oceania 2
Totale 525
Nazione #
US - Stati Uniti d'America 311
IT - Italia 98
CN - Cina 22
GB - Regno Unito 14
DE - Germania 13
CA - Canada 8
FR - Francia 8
IE - Irlanda 5
ES - Italia 4
JP - Giappone 4
BR - Brasile 3
NO - Norvegia 3
RU - Federazione Russa 3
VN - Vietnam 3
ZM - Zambia 3
AR - Argentina 2
AU - Australia 2
IN - India 2
KR - Corea 2
NL - Olanda 2
PE - Perù 2
ZA - Sudafrica 2
BE - Belgio 1
BW - Botswana 1
CL - Cile 1
FI - Finlandia 1
GR - Grecia 1
NG - Nigeria 1
NP - Nepal 1
TH - Thailandia 1
TW - Taiwan 1
Totale 525
Città #
Milan 53
Fairfield 50
Woodbridge 36
Seattle 26
Buffalo 25
Cambridge 23
Houston 22
Ashburn 20
Wilmington 17
Santa Cruz 14
Cork 5
Montréal 5
Ann Arbor 4
Chengdu 4
Henderson 4
Las Vegas 4
Southend 4
Clearwater 3
Genoa 3
Nanjing 3
Phoenix 3
Beijing 2
Brescia 2
Chiavari 2
Dong Ket 2
Honolulu 2
Lima 2
Munro 2
Oslo 2
Ottawa 2
Palermo 2
Rome 2
Torrelodones 2
Wuhan 2
Alghero 1
Austin 1
Bath 1
Blackburn 1
Bloomsbury 1
Bologna 1
Büdelsdorf 1
Cardiff 1
Castro Valley 1
Changchun 1
Chaoyang 1
Dortmund 1
Dubino 1
Easton 1
Fishers 1
Frankfurt Am Main 1
Fremont 1
Grafing 1
Guangzhou 1
Hangzhou 1
Hefei 1
Jawalakhel 1
Karlsruhe 1
Legnano 1
London 1
Los Angeles 1
Ludwigshafen 1
Messina 1
Milpitas 1
Moscow 1
Mountain View 1
Muizenberg 1
Munich 1
New Delhi 1
New Kensington 1
Nutley 1
Oakland 1
Padova 1
Pasadena 1
Paulista 1
Portland 1
Quartu Sant'elena 1
Red Bank 1
Richmond 1
Riva 1
Rochester 1
Saint Albans 1
Saint-laurent 1
San Diego 1
San Francisco 1
Sassari 1
Seoul 1
Shanghai 1
Stockport 1
Stuttgart 1
Sydney 1
Taipei 1
Taramani 1
Trento 1
Valencia 1
Vladimir 1
Totale 415
Nome #
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART, file dfa8b99e-1181-748b-e053-3a05fe0a3a96 236
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy : a multicenter retrospective cohort study from 2007 to 2015, file dfa8b99d-d80f-748b-e053-3a05fe0a3a96 97
Determinants of patient and health care services delays for tuberculosis diagnosis in Italy : a cross-sectional observational study, file dfa8b99e-29ef-748b-e053-3a05fe0a3a96 92
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases, file dfa8b9a1-86c5-748b-e053-3a05fe0a3a96 78
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial, file dfa8b99f-8c7e-748b-e053-3a05fe0a3a96 18
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy : an observational cohort study, file dfa8b996-d53b-748b-e053-3a05fe0a3a96 8
Unexpected viral relapses in hepatitis C virus-€“infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals, file dfa8b99e-1961-748b-e053-3a05fe0a3a96 6
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment, file dfa8b996-8f2c-748b-e053-3a05fe0a3a96 5
Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss, file dfa8b9a9-f980-748b-e053-3a05fe0a3a96 4
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy, file dfa8b99d-cef2-748b-e053-3a05fe0a3a96 3
3-Year efficacy and durability of simplification to single tablet regimens : a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir, file dfa8b99d-e8ae-748b-e053-3a05fe0a3a96 3
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014, file dfa8b99e-294a-748b-e053-3a05fe0a3a96 3
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial, file dfa8b9a0-b362-748b-e053-3a05fe0a3a96 3
Real-world experience of tocilizumab in rheumatoid arthritis : sub-analysis of data from the Italian biologics’ register GISEA, file dfa8b99e-153b-748b-e053-3a05fe0a3a96 2
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort, file dfa8b9a1-e9a0-748b-e053-3a05fe0a3a96 2
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort, file dfa8b9a3-9932-748b-e053-3a05fe0a3a96 1
Totale 561
Categoria #
all - tutte 629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182 0000 00 00 2000
2018/201983 0010 00 00 0263224
2019/2020184 16111115 1526 1314 1623519
2020/2021166 4151211 415 1212 21331710
2021/2022108 1013612 92 58 352510
2022/20238 6200 00 00 0000
Totale 561